Related references
Note: Only part of the references are listed.Juvenile amyotrophic lateral sclerosis associated with biallelic c.757delG mutation of sorbitol dehydrogenase gene
Emilien Bernard et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2022)
A National French Consensus on Gene List for the Diagnosis of Charcot-Marie-Tooth Disease and Related Disorders Using Next-Generation Sequencing
Thibaut Benquey et al.
GENES (2022)
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy
Bianca R. Grosz et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2022)
Distal hereditary motor neuropathies: Mutation spectrum and genotype-phenotype correlation
Marina Frasquet et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Evaluation of SORD mutations as a novel cause of Charcot-Marie-Tooth disease
Ru-Ying Yuan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Biallelic SORD pathogenic variants cause Chinese patients with distal hereditary motor neuropathy
Hai-Lin Dong et al.
NPJ GENOMIC MEDICINE (2021)
Clinical and Genetic Features of Biallelic Mutations in SORD in a Series of Chinese Patients With Charcot-Marie-Tooth and Distal Hereditary Motor Neuropathy
Xiaoxuan Liu et al.
FRONTIERS IN NEUROLOGY (2021)
Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patients
P. Lassuthova et al.
SCIENTIFIC REPORTS (2021)
Genotype-phenotype correlation in French patients with myelin protein zero gene-related inherited neuropathy
Marie Subreville et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
Andrea Cortese et al.
NATURE GENETICS (2020)
Genetic and Clinical Features in 24 Chinese Distal Hereditary Motor Neuropathy Families
Yongzhi Xie et al.
FRONTIERS IN NEUROLOGY (2020)
Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double-blind placebo-controlled study in Japan
Kenji Sekiguchi et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Development and validation of a quantitative ultra performance LC® hydrophilic interaction liquid chromatography MS/MS method to measure fructose and sorbitol in human plasma
Fumin Li et al.
BIOANALYSIS (2019)
Charcot-Marie-Tooth: From Molecules to Therapy
Jonathan Morena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
VarSome: the human genomic variant search engine
Christos Kopanos et al.
BIOINFORMATICS (2019)
Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation
Juliette Bacquet et al.
BMJ OPEN (2018)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Fructose Levels Are Markedly Elevated in Cerebrospinal Fluid Compared to Plasma in Pregnant Women
Janice J. Hwang et al.
PLOS ONE (2015)
The distal hereditary motor neuropathies
Alexander M. Rossor et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease
Sinead M. Murphy et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
Kate E. Schemmel et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications
Nick Giannoukakis
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
The role of polyol pathway in high glucose-induced endothelial cell damages
Tomokazu Oyama et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy - The 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial
Nigishi Hotta et al.
DIABETES CARE (2006)
Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy
V Bril et al.
DIABETES CARE (2004)
Review on uremic toxins:: Classification, concentration, and interindividual variability
R Vanholder et al.
KIDNEY INTERNATIONAL (2003)
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy - A 52-week multicenter placebo-controlled double-blind parallel group study
N Hotta et al.
DIABETES CARE (2001)